Pharmaceutical Company and Former Executives Charged With Misleading Financial Disclosures

The Securities and Exchange Commission today announced that Bausch Health, formerly Quebec, Canada-based Valeant Pharmaceuticals, agreed to pay a $45 million penalty to settle charges of improper revenue recognition and misleading disclosures in SEC…

close

Get every new post delivered right to your inbox.

Original Source